+8618116577817
sinobiopharm@gmail.com
Home
Products
News
About
Contact
NEWS
Company News
Industry News
2025-08-12
[Retail Market] Market Analysis Report on the "Ibuprofen" Variety of Antipyretic, Analgesic, and Anti-inflammatory Drugs
Capsules are the main dosage form of the "Ibuprofen" variety, and their market share in retail pharmacies has been increasing year by year.
2025-08-05
[Retail Market] "Ganmao Ling Granules & Compound Ganmao Ling Granules" Product Market Analysis Report
The monthly sales trends of Ganmaoling Granules and Compound Ganmaoling Granules at the retail end tend to be consistent.
2025-07-24
[PIDC - Market Insights and Consumer Research] Analysis of Ophthalmic Drug "Sodium Hyaluronate Eye Drops"
Since entering the new century, China has become one of the countries with the largest number of patients suffering from ophthalmic diseases worldwide. The market size and demand for ophthalmic drugs have rapidly increased. According to data from Yaozhi, the ophthalmic drug market has grown from 16.7 billion yuan in 2020 to 23 billion yuan in 2024. Across all terminals, the market size of the eye drop industry has increased from 10.4 billion yuan in 2020 to approximately 13.2 billion yuan in 2024. Among these, eye drops for treating dry eye syndrome occupy a significant portion of the ophthalmic market, with "artificial tears" sodium hyaluronate eye drops being one of the main drugs for treating dry eye syndrome, achieving sales of 2.5 billion yuan in 2024.
Panorama of China's Pharmaceutical Patents in the First Half of 2025: What Innovation Secrets Lie Behind the Leading Medical Devices?
Against the backdrop of increasingly intense global pharmaceutical industry competition and accelerated technological innovation iterations, China's pharmaceutical sector is undergoing a critical phase of transformation from "quantitative accumulation" to "qualitative leap." Patents, as a core indicator of technological innovation, reflect the industry's development trends and strategic focus through changes in their quantity and structure. In the first half of 2025, the number of pharmaceutical patents granted by the National Intellectual Property Administration showed a year-on-year decline, while distinct phase characteristics appeared in aspects such as technology types and applicant composition. This report, based on information from the National Intellectual Property Administration and Yaozhi Data, systematically reviews the patent authorization dynamics in China's pharmaceutical field in the first half of 2025, analyzes the driving factors and industry impacts behind them, and provides references for industrial innovation planning.
![[PIDC - Market Insights and Consumer Research] Analysis of Ophthalmic Drug "Sodium Hyaluronate Eye Drops"](/npublic/img/s.png "[PIDC - Market Insights and Consumer Research] Analysis of Ophthalmic Drug \"Sodium Hyaluronate Eye Drops\"")